XTX Markets’s Foamix Pharmaceuticals Ltd. Ordinary Shares FOMX Stock Holding History

XTX Markets’s Portfolio FOMX Stock Details FOMX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-12,702	Closed	-$42K	–	155
2019 Q4	$42K	Buy	+12,702	New	+$40.4K	0.3%	63

XTX Markets's FOMX Position: Q1 2020 in Review

XTX Markets sold out of Foamix Pharmaceuticals Ltd. Ordinary Shares (FOMX) in Q1 2020, closing a stake of 12,702 shares — an estimated $42K sold.

XTX Markets first reported a position in FOMX in Q4 2019 and held it in 1 quarter. The position peaked at $42K in Q4 2019. 3 funds tracked by Wall St. Rank hold FOMX as of Q1 2020.

XTX Markets reported no remaining Foamix Pharmaceuticals Ltd. Ordinary Shares position as of Q1 2020 after selling out during the quarter.
XTX Markets sold 12,702 Foamix Pharmaceuticals Ltd. Ordinary Shares shares in Q1 2020, an estimated $42K.
XTX Markets first reported a position in Foamix Pharmaceuticals Ltd. Ordinary Shares in Q4 2019 and held it in 1 quarter.
XTX Markets's Foamix Pharmaceuticals Ltd. Ordinary Shares position peaked at $42K in Q4 2019.
3 funds tracked by Wall St. Rank held Foamix Pharmaceuticals Ltd. Ordinary Shares as of Q1 2020.

Based on XTX Markets's 13F filing for Q1 2020, filed 20 Apr 2020.